EmeTerm
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
422 Richards St Unit 170, Vancouver, Bri...Phone Number
(805) 852-6820Website
www.emeterm.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About EmeTerm
EmeTerm is a company that specializes in clinically proven wearable devices designed to prevent and relieve nausea and vomiting caused by motion sickness and morning sickness. Their product line includes various models of anti-nausea wristbands, such as EmeTerm Smart, EmeTerm Explore, and EmeTerm Explore for Kids, catering to different age groups and preferences. The company also offers HeadaTerm, a device aimed at treating migraines through non-invasive electrical stimulation. EmeTerm targets clients who experience motion sickness, morning sickness, and migraines, providing a drug-free solution with a high success rate.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EmeTerm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when EmeTerm launches new products
Website visits: Recent activity has been detected on your website
Click to see if EmeTerm had a recent Job posting/layoffs
Funding: Get notified immidiatlly once EmeTerm has new funding data
Earning: See what the market has to say on EmeTerm recently announced quarterly report
Check if EmeTerm has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at EmeTerm
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if EmeTerm is spiking on competitors!
EmeTerm, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to EmeTerm
Compare insights from companies similar to EmeTerm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
EmeTerm
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
EmeTerm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
EmeTerm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about EmeTerm.
EmeTerm Tech Stack
A closer look at the technologies used by EmeTerm
EmeTerm News & Media
U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting
VANCOUVER, BC, Aug. 17, 2026 /PRNewswire/ -- Participant recruitment information for a clinical study being conducted at The Ohio State University has been publicly posted on ClinicalTrials.gov. The study, titled "Evaluating the Effect of Wearing a TENS Device in Nausea Relief," is also known as the WINNER Study. It is registered under ClinicalTrials.gov identifier NCT07720323 and is currently listed as recruiting. The study is sponsored by The Ohio State University and is expected to enrollWAT Medical's EmeTerm Wearable Device Demonstrates Superior Control of Moderate to Severe Postoperative Nausea and Vomiting in JAMA Surgery-Published Clinical Trial
VANCOUVER, BC, Feb. 9, 2026 /PRNewswire/ -- WAT Medical is proud to announce the publication of a landmark randomized clinical trial in JAMA Surgery, one of the world's most reputable and high-impact surgical journals. The study confirms that the EmeTerm wristband — a wearable device...EmeTerm Wristband Significantly Reduces Postoperative Nausea and Vomiting in Major Orthopedic Surgeries
VANCOUVER, BC, Nov. 3, 2025 /PRNewswire/ -- WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits of the EmeTerm wristband in reducing postoperative nausea and vomiting (PONV) in patients undergoing total hip or knee arthroplasty (THA/TKA) under spinal anesthesia. The study aimed to evaluate whether the addition of the EmeTerm wristband to conventional antiemetic tEmeTerm Wearable Device Under Clinical Study at Ohio State Wexner Medical Center Shows Promise for Chronic Nausea Patients
VANCOUVER, BC, Sept. 15, 2025 /PRNewswire/ -- WAT Medical Enterprise Ltd. is proud to announce that its innovative anti-nausea wristband, EmeTerm, has made significant progress in alleviating nausea and vomiting among patients suffering from chronic gastric disorders. A clinical study currently underway at The Ohio State University Wexner Medical Center is evaluating the device's impact on individuals with moderate to severe chronic nausea, a condition that affects millions worldwide. A Growing
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding EmeTerm
Sign Up For FreeTo access detailed company insights
EmeTerm is a company that specializes in clinically proven wearable devices designed to prevent and relieve nausea and vomiting caused by motion sickness and morning sickness. Their product line includes various models of anti-nausea wristbands, such as EmeTerm Smart, EmeTerm Explore, and EmeTerm Explore for Kids, catering to different age groups a... Read More
